Suzhou Highfine Biotech Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE1000064T6
CNY
50.12
-8.03 (-13.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
133.85
133.80
122.09
102.41
132.57
90.63
84.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
133.85
133.80
122.09
102.41
132.57
90.63
84.20
Raw Material Cost
81.28
85.39
80.23
58.80
80.27
58.65
57.74
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.02
0.03
0.06
0.01
0.01
0.02
0.02
Selling and Distribution Expenses
10.18
11.06
8.55
9.94
15.72
8.29
8.52
Other Expenses
0.78
0.82
0.85
0.81
0.53
0.91
0.74
Total Expenditure (Excl Depreciation)
99.24
104.69
97.31
76.82
101.27
76.09
73.66
Operating Profit (PBDIT) excl Other Income
34.6
29.1
24.8
25.6
31.299999999999997
14.5
10.5
Other Income
8.26
10.36
23.55
1.40
11.79
18.79
18.23
Operating Profit (PBDIT)
49.63
46.07
52.82
34.17
43.94
38.23
29.28
Interest
0.02
0.03
0.06
0.01
0.01
0.02
0.02
Exceptional Items
4.13
1.32
-2.90
6.69
1.57
0.28
-2.74
Gross Profit (PBDT)
52.56
48.40
41.86
43.60
52.30
31.98
26.46
Depreciation
6.99
6.99
5.78
5.78
4.26
4.26
4.07
Profit Before Tax
46.75
40.37
44.09
35.08
41.24
34.23
22.45
Tax
5.66
5.57
6.37
4.55
5.26
4.40
2.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
41.09
34.80
37.72
30.53
35.98
29.83
20.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
41.09
34.80
37.72
30.53
35.98
29.83
20.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.09
34.80
37.72
30.53
35.98
29.83
20.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,318.85
2,305.48
2,268.27
2,241.95
2,220.24
2,232.54
2,211.86
Earnings per share (EPS)
0.38
0.32
0.35
0.29
0.34
0.28
0.19
Diluted Earnings per share
0.38
0.32
0.35
0.29
0.34
0.28
0.19
Operating Profit Margin (Excl OI)
25.69%
21.46%
19.24%
26.36%
21.04%
16.74%
8.29%
Gross Profit Margin
40.15%
35.39%
40.84%
39.89%
34.32%
42.47%
31.49%
PAT Margin
30.7%
26.01%
30.89%
29.81%
27.14%
32.91%
23.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.90% vs 56.18% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 14.17% vs 60.71% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 28.57% vs 24.32% in Jun 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Suzhou Highfine Biotech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
133.85
0
133.85
Other Operating Income
0.00
0.00
0.00
Total Operating income
133.85
0
133.85
Raw Material Cost
81.28
0
81.28
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.02
0
0.02
Selling and Distribution Expenses
10.18
0
10.18
Other Expenses
0.78
0.00
0.78
Total Expenditure (Excl Depreciation)
99.24
0
99.24
Operating Profit (PBDIT) excl Other Income
34.61
0.00
34.61
Other Income
8.26
0
8.26
Operating Profit (PBDIT)
49.63
0
49.63
Interest
0.02
0
0.02
Exceptional Items
4.13
0
4.13
Gross Profit (PBDT)
52.56
0
52.56
Depreciation
6.99
0
6.99
Profit Before Tax
46.75
0
46.75
Tax
5.66
0
5.66
Provisions and contingencies
0
0
0.00
Profit After Tax
41.09
0
41.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
41.09
0
41.09
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.09
0
41.09
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,318.85
0
2,318.85
Earnings per share (EPS)
0.38
0
0.38
Diluted Earnings per share
0.38
0
0.38
Operating Profit Margin (Excl OI)
25.69%
0%
0.00
25.69%
Gross Profit Margin
40.15%
0%
0.00
40.15%
PAT Margin
30.70%
0%
0.00
30.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 13.38 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 9.58% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.90% vs 56.18% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.11 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 18.10% vs -7.69% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.17% vs 60.71% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.14 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 15.97% vs 21.84% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 28.57% vs 24.32% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.69%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024